Section one: Contracting authority
one.1) Name and addresses
NHS England
7-8 Wellington Place
Leeds
LS1 4AP
jessica.gaucher-thompson@nhs.net
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
MR-guided Laser Interstitial Thermal Therapy (MRgLITT) for treatment of epileptogenic zones for Adults with refractory focal epilepsy
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Specialised Commissioning (referred to as the Commissioner), invited suitably qualified and experienced providers to bid for an opportunity to provide MR-guided Laser Interstitial Thermal Therapy (MRgLITT) for treatment of epileptogenic zones for adults with refractory focal epilepsy (Lot 1: North & Lot 2: South). As a result of this procurement exercise the Commissioner has awarded contracts for these services.
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £2,153,100
two.2) Description
two.2.1) Title
A. Lot 1- North
Lot No
1
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
two.2.4) Description of the procurement
MRgLITT, also known as ‘laser interstitial thermal therapy’ (LITT), is a minimally invasive treatment which can be used in focal refractory epilepsy. Stereotactic neurosurgical technique is used to guide a 3mm diameter fibreoptic laser to the target area of the brain. Under continuous MRI monitoring, laser energy is applied to the target area to destroy the part of the brain causing seizure activity. It is safer than open neurosurgery as there is less risk of collateral damage to other structures in the brain. Open surgery causes damage along the operative pathway to access the part to be removed, which is mitigated by this minimally invasive approach.
The service will commence on 1st September 2024 and will run for a duration of 5 years (initial
period). The Commissioner has the option to extend for up to a further 2 years making a
possible maximum contract duration of 7 years.
two.2.5) Award criteria
Quality criterion - Name: Quality (Service Delivery / Technical) / Weighting: 90%
Quality criterion - Name: Social Value / Weighting: 10%
Cost criterion - Name: N/A / Weighting: 0%
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
B. Lot 2 - South
Lot No
2
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
MRgLITT, also known as ‘laser interstitial thermal therapy’ (LITT), is a minimally invasive treatment which can be used in focal refractory epilepsy. Stereotactic neurosurgical technique is used to guide a 3mm diameter fibreoptic laser to the target area of the brain. Under continuous MRI monitoring, laser energy is applied to the target area to destroy the part of the brain causing seizure activity. It is safer than open neurosurgery as there is less risk of collateral damage to other structures in the brain. Open surgery causes damage along the operative pathway to access the part to be removed, which is mitigated by this minimally invasive approach.
The service commenced on 23rd July 2024 and will run for a duration of 5 years (initial
period). The Commissioner has the option to extend for up to a further 2 years making a
possible maximum contract duration of 7 years.
two.2.5) Award criteria
Quality criterion - Name: Quality (Service Delivery / Technical) / Weighting: 90%
Quality criterion - Name: Social Value / Weighting: 10%
Cost criterion - Name: N/A / Weighting: 0%
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2023/S 000-023997
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
17 July 2024
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
The Walton Centre NHS Foundation Trust
Liverpool
L9 7LJ
Country
United Kingdom
NUTS code
- UKD7 - Merseyside
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1,033,500
Total value of the contract/lot: £1,033,500
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
15 August 2024
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
King's College Hospital NHS Foundation Trust
London
SE5 9RS
Country
United Kingdom
NUTS code
- UKI4 - Inner London – East
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1,119,600
Total value of the contract/lot: £1,119,600
Section six. Complementary information
six.3) Additional information
Link to Clinical Commissioning Policy:
https://www.england.nhs.uk/wp-content/uploads/2022/10/2006-Clinical-commissioning-policy-MR-guided-laser-interstitial-thermal-therapy-for-treatment-of-epileptogenic.pdf
The procurement was advertised and conducted in accordance with the requirements of the Public Contracts Regulations 2015 (as amended) (the “Regulations”) to the extent that the Regulations relate to services within the scope of Schedule 3 thereto (Social and Other Specific Services). The Commissioner and AGCSU are, therefore, bound only by those parts of the Regulations applying to Schedule 3 services.
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom